Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Hybridon and the Institute of Human Virology enter antisense AIDS therapy collaboration

May 6, 1997

Anti-HIV antisense oligonucleotides from Hybridon evaluated in SCID mice

May 5, 1997

Potent inhibitors of HIV-1 and other enveloped viruses reported

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Joint venture created to develop calanolide A as anti-HIV treatment

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

DuPont Merck describes potent, orally bioavailable cyclic urea HIV protease inhibitor

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...